Clinical Trial

A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance for the Detection of Calcified Coronary Arteries

Recruiting
View on ClinicalTrials.gov →
Summary
This study is a single-center, prospective, controlled, diagnostic study. The study will be consecutive and is expected to enroll 100 patients with CCTA confirmed coronary calcified lesions. The purpose of this study was to compare the accuracy of novel Ferumoxytol-enhanced Cardiac Magnetic Resonance (Fe-CMR) and coronary CT angiography (CCTA) in detecting calcified coronary arteries, using coronary angiography (CAG) and optical coherence imaging (OCT) as gold standards.
Trial Details
NCT Number NCT07400406
Lead Sponsor The First Affiliated Hospital with Nanjing Medical University
Collaborators: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Conditions Coronary Artery Calcification
Enrollment 100 participants
Start Date 2024-01-26
Primary Completion 2027-08-31 (estimated)
Study Completion 2027-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-10